Clinical Trial Update: Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium.

View source ↗

Summary

A completed study in non-small cell lung cancer in Antwerp evaluated whether timely analysis of EGFR mutation status is feasible in the region.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Non Small Cell Lung Cancer | Status: COMPLETED